HANNAH BUMGARNER: Open Payments
NPI 1477139103 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 14 payments from 8 companies in 2025. Trend: 2023 $60 · 2024 $168 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $115 |
| Gilead Sciences, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Theratechnologies Inc. | 1 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $23 |
| Insmed, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
Products named: DOVATO, RUKOBIA, EGRIFTA, VOWST, Rezzayo, Arikayce, CABENUVA, ZERBAXA.
Industry payments across SC — which companies pay providers there.
